SVT-40776
| CAS No. | 385367-47-5 | Cat. No. | BCP22673 |
| Name | SVT-40776 | ||
| Synonyms | SVT40776; Tarafenacin; SVT 40776; | ||
| Formula | C25H26F4N2O8 | M. Wt | 408.39 |
| Description | Tarafenacin, also known as SVT-40776, is a novel M3 muscarinic receptor antagonist under development for the treatment of overactive bladder. SVT-40776 shows highly selective for M(3) over M(2) receptors (Ki = 0.19 nmol.L(-1) for M(3) receptor affinity). SVT-40776 is a potent inhibitor of M(3) receptor-related detrusor contractile activity. The absence of effects on isolated atria preparations represents an interesting characteristic and suggests that SVT-40776 may lack unwanted cardiac effects; a feature especially relevant in a compound intended to treat mainly elderly patients. | ||
| Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | mAChR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.